1
|
Nicolaou KC, Rigol S. Perspectives from nearly five decades of total synthesis of natural products and their analogues for biology and medicine. Nat Prod Rep 2020; 37:1404-1435. [PMID: 32319494 PMCID: PMC7578074 DOI: 10.1039/d0np00003e] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Covering: 1970 to 2020By definition total synthesis is the art and science of making the molecules of living Nature in the laboratory, and by extension, their analogues. Although obvious, its application to the synthesis of molecules for biology and medicine was not always the purpose of total synthesis. In recent years, however, the field has acquired momentum as its power to reach higher molecular complexity and diversity is increasing, and as the demand for rare bioactive natural products and their analogues is expanding due to their recognised potential to facilitate biology and drug discovery and development. Today this component of total synthesis endeavors is considered highly desirable, and could be part of interdisciplinary academic and/or industrial partnerships, providing further inspiration and momentum to the field. In this review we provide a brief historical background of the emergence of the field of total synthesis as it relates to making molecules for biology and medicine. We then discuss specific examples of this practice from our laboratories as they developed over the years. The review ends with a conclusion and future perspectives for natural products chemistry and its applications to biology and medicine and other added-value contributions to science and society.
Collapse
Affiliation(s)
- K C Nicolaou
- Department of Chemistry, Rice University, 6100 Main Street, Houston, Texas 77005, USA.
| | | |
Collapse
|
2
|
Synthesis of the thiazole-containing C11–C21-block of a gem-dimethylcyclopropane derivative of epothilones. MENDELEEV COMMUNICATIONS 2009. [DOI: 10.1016/j.mencom.2009.09.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
3
|
Abstract
Our bodies are made of molecules, and it is from molecules that we derive our strength and joys. The joys of molecules manifest themselves in many ways. These include beautiful colors, exquisite aromas, distinct tastes, psychological ups and downs, and intellectual inspirations, among other forms of stimulation, material or spiritual. In this Perspective, written on the occasion of the 2005 American Chemical Society Arthur C. Cope Award address, I recount some of the joys I have experienced and shared with my students during campaigns to synthesize some of Nature's most intriguing and complex molecules.
Collapse
Affiliation(s)
- K C Nicolaou
- Department of Chemistry and Skaggs Institute for Chemical Biology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
| |
Collapse
|
4
|
Zheng Y, Avery MA. Asymmetric aldol reactions using catalytic d(+)-proline: a new, economic and practical approach to a commonly employed C1–C6 keto-acid synthon of the epothilones. Tetrahedron 2004. [DOI: 10.1016/j.tet.2003.12.048] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
|
6
|
Stachel SJ, Danishefsky SJ. Chemo- and stereoselective epoxidation of 12,13-desoxyepothilone B using 2,2′-dimethyldioxirane. Tetrahedron Lett 2001. [DOI: 10.1016/s0040-4039(01)01209-6] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Martin HJ, Pojarliev P, Kählig H, Mulzer J. The 12,13-diol cyclization approach for a truly stereocontrolled total synthesis of epothilone B and the synthesis of a conformationally restrained analogue. Chemistry 2001; 7:2261-71. [PMID: 11411998 DOI: 10.1002/1521-3765(20010518)7:10<2261::aid-chem2261>3.0.co;2-f] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
A highly convergent and stereocontrolled synthesis of epothilone B (1) has been developed. The epoxide moiety in 1 was generated by regioselective mesylation and base treatment of the 12,13-diol 30 which was formed by a chelate Cram controlled Grignard addition of 14 and methyl ketone 13. Both fragments were synthesized from the chiral carbon pool precursors (S)-citronellol and (S)-lactic acid, respectively. A highly diastereoselective aldol addition of epoxy-aldehyde 7 and the known Southern hemisphere ketone 8 delivered the full carbon skeleton, containing all the stereogenic centers of 1. Functional group manipulation, macrolactonization and removal of two protecting groups then yielded 1. The spatial closeness of the C4-beta-methyl and C6-methyl group in the crystal structure of 1 inspired us to connect them through a methylene bridge to give a cyclohexanone derivative. Thus, the Northern hemisphere aldehyde 7 was added to the enolate of the cyclohexanone 47. Further manipulations and macrolactonization delivered the conformationally restrained epothilone derivative 42.
Collapse
Affiliation(s)
- H J Martin
- Institut für Organische Chemie der Universität Wien, Austria.
| | | | | | | |
Collapse
|
8
|
Sinha SC, Sun J, Miller GP, Wartmann M, Lerner RA. Catalytic Antibody Route to the Naturally Occurring Epothilones: Total Synthesis of Epothilones A-F. Chemistry 2001; 7:1691-702. [PMID: 11349910 DOI: 10.1002/1521-3765(20010417)7:8<1691::aid-chem16910>3.0.co;2-9] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Naturally occurring epothilones have been synthesized starting from enantiomerically pure aldol compounds 9-11, which were obtained by antibody catalysis. Aldolase antibody 38C2 catalyzed the resolution of (+/-)-9 by enantioselective retro-aldol reaction to afford 9 in 90% ee at 50 % conversion. Compounds 10 and 11 were obtained in more than 99% ee at 50% conversion by resolution of their racemic mixtures using newly developed aldolase antibodies 84G3, 85H6 or 93F3. Compounds 9, 10 and 11 were resolved in multigram quantities and then converted to the epothilones by metathesis processes, which were catalyzed by Grubbs' catalysts.
Collapse
Affiliation(s)
- S C Sinha
- Department of Molecular Biology and the Skaggs Institute for Chemical Biology, the Scripps Research Institute, La Jolla, California 92037, USA.
| | | | | | | | | |
Collapse
|
9
|
Methodology Based on Chiral Silanes in the Synthesis of Polypropionate‐Derived Natural Products − Total Synthesis of Epothilone A. European J Org Chem 2001. [DOI: 10.1002/1099-0690(200105)2001:9<1701::aid-ejoc1701>3.0.co;2-#] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
10
|
Nicolaou KC, Snyder SA, Simonsen KB, Koumbis AE. Model Studies towards Diazonamide A: Synthesis of the Heterocyclic Core We thank Dr. D. H. Huang, Dr. G. Suizdak, and Dr. R. Chadha for NMR spectroscopic, mass spectrometric, and X-ray crystallographic assistance, respectively. We also thank Professor R. H. Grubbs for a generous gift of catalyst 30. Financial support for this work was provided by The Skaggs Institute for Chemical Biology, the National Institutes of Health (USA), a predoctoral fellowship from the National Science Foundation (S.A.S.), postdoctoral fellowships from the Alfred Benzons Foundation and the Danish Natural Science Research Council (K.B.S.), and grants from Abbott, Amgen, ArrayBiopharma, Boehringer-Ingelheim, GlaxoWellcome, Hoffmann-LaRoche, DuPont, Merck, Novartis, Pfizer, and Schering Plough. Angew Chem Int Ed Engl 2000; 39:3473-3478. [PMID: 11091394 DOI: 10.1002/1521-3773(20001002)39:19<3473::aid-anie3473>3.0.co;2-e] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- KC Nicolaou
- Department of Chemistry and The Skaggs Institute for Chemical Biology The Scripps Research Institute 10550 North Torrey Pines Road, La Jolla, CA 92037 (USA) and Department of Chemistry and Biochemistry University of California San Diego 9500 Gilman Drive, La Jolla, CA 92093 (USA)
| | | | | | | |
Collapse
|
11
|
|
12
|
Borzilleri RM, Zheng X, Schmidt RJ, Johnson JA, Kim SH, DiMarco JD, Fairchild CR, Gougoutas JZ, Lee FYF, Long BH, Vite GD. A Novel Application of a Pd(0)-Catalyzed Nucleophilic Substitution Reaction to the Regio- and Stereoselective Synthesis of Lactam Analogues of the Epothilone Natural Products. J Am Chem Soc 2000. [DOI: 10.1021/ja001899n] [Citation(s) in RCA: 115] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Robert M. Borzilleri
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - Xiaoping Zheng
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - Robert J. Schmidt
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - James A. Johnson
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - Soong-Hoon Kim
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - John D. DiMarco
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - Craig R. Fairchild
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - Jack Z. Gougoutas
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - Francis Y. F. Lee
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - Byron H. Long
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| | - Gregory D. Vite
- Contribution from the Divisions of Discovery Chemistry, Oncology Drug Discovery, and Analytical Research and Development, The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543-4000
| |
Collapse
|
13
|
Nicolaou KC, King NP, Finlay MR, He Y, Roschangar F, Vourloumis D, Vallberg H, Sarabia F, Ninkovic S, Hepworth D. Total synthesis of epothilone E and related side-chain modified analogues via a Stille coupling based strategy. Bioorg Med Chem 1999; 7:665-97. [PMID: 10400321 DOI: 10.1016/s0968-0896(98)00153-9] [Citation(s) in RCA: 72] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
A Stille coupling strategy has been utilized to complete a total synthesis of epothilone E from vinyl iodide 7 and thiazole-stannane 8h. The central core fragment 7 and its trans-isomer 11 were prepared from triene 15 using ring-closing metathesis (RCM), and were subsequently coupled to a variety of alternative stannanes to provide a library of epothilone analogues 18a-o and 19a-o. The Stille coupling approach was then used to prepare epothilone B analogues from the key macrolactone intermediate 24 which was itself synthesized by a macrolactonization based strategy.
Collapse
Affiliation(s)
- K C Nicolaou
- Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Sinha SC, Barbas CF, Lerner RA. The antibody catalysis route to the total synthesis of epothilones. Proc Natl Acad Sci U S A 1998; 95:14603-8. [PMID: 9843936 PMCID: PMC24496 DOI: 10.1073/pnas.95.25.14603] [Citation(s) in RCA: 73] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
An efficient monoclonal aldolase antibody that proceeds by an enamine mechanism was generated by reactive immunization. Here, this catalyst has been used in the total synthesis of epothilones A (1) and C (3). The starting materials for the synthesis of these molecules have been obtained by using antibody-catalyzed aldol and retro-aldol reactions. These precursors were then converted to epothilones A (1) and C (3) to complete the total synthesis.
Collapse
Affiliation(s)
- S C Sinha
- The Skaggs Institute for Chemical Biology and the Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. or
| | | | | |
Collapse
|
15
|
Sefkow M, Kiffe M, Schummer D, Höfle G. Oxidative and reductive transformations of epothilone A. Bioorg Med Chem Lett 1998; 8:3025-30. [PMID: 9873669 DOI: 10.1016/s0960-894x(98)00545-9] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The C7 hydroxy group of cytotoxic epothilone A was selectively oxidized using PDC. A selective oxidation of the C3 hydroxy group was accomplished with Me2S/(PhCO2)2 after in situ protection of C7-OH. Reduction of epothilone A or of a C5, C7 dioxo derivative with NaBH4 proceeded at the C5 carbonyl group. Oxidation and hydrogenation of the C16-C17 double bond proved to be difficult but it was easily cleaved with ozone and the resulting keto derivative was transformed to epothilone analogs with different side chains.
Collapse
Affiliation(s)
- M Sefkow
- Gesellschaft für Biotechnologische Forschung mbH, Abt. Naturstoffchemie, Braunschweig, Germany.
| | | | | | | |
Collapse
|
16
|
Balog A, Harris C, Savin K, Zhang XG, Chou TC, Danishefsky SJ. Eine neuartige Aldolkondensation mit 2-Methyl-4-pentenal und ihr Einsatz in einer verbesserten Totalsynthese von Epothilon B. Angew Chem Int Ed Engl 1998. [DOI: 10.1002/(sici)1521-3757(19981002)110:19<2821::aid-ange2821>3.0.co;2-g] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
17
|
|
18
|
Nicolaou KC, Finlay MR, Ninkovic S, King NP, He Y, Li T, Sarabia F, Vourloumis D. Synthesis and biological properties of C12,13-cyclopropyl-epothilone A and related epothilones. CHEMISTRY & BIOLOGY 1998; 5:365-72. [PMID: 9662505 DOI: 10.1016/s1074-5521(98)90070-9] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND The epothilones are natural substances that are potently cytotoxic, having an almost identical mode of action to Taxoltrade mark as tubulin-polymerization and microtubule-stabilizing agents. The development of detailed structure-activity relationships for these compounds and the further elucidation of their mechanism of action is of high priority. RESULTS The chemical synthesis of the C12,13-cyclopropyl analog of epothilone A and its C12,13-trans-diastereoisomer has been accomplished. These compounds and several other epothilone analogs have been screened for their ability to induce tubulin polymerization and death of a number of tumor cells. Several interesting structure-activity trends within this family of compounds were identified. CONCLUSIONS The results of the biological tests conducted in this study have demonstrated that, although a number of positions on the epothilone skeleton are amenable to modification without significant loss of biological activity, the replacement of the epoxide moiety of epothilone A with a cyclopropyl group leads to total loss of activity.
Collapse
Affiliation(s)
- K C Nicolaou
- Department of Chemistry The Skaggs Institute for Chemical Biology The Scripps Research Institute 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Total synthesis of 26-hydroxy-epothilone B and related analogs via a macrolactonization based strategy. Tetrahedron 1998. [DOI: 10.1016/s0040-4020(98)00352-4] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
20
|
Nicolaou K, He Y, Roschangar F, King N, Vourloumis D, Li T. Totalsynthese von Epothilon E und seitenkettenmodifizierten Epothilon-Analoga durch Stille-Kupplung. Angew Chem Int Ed Engl 1998. [DOI: 10.1002/(sici)1521-3757(19980116)110:1/2<89::aid-ange89>3.0.co;2-t] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
21
|
Nicolaou K, Sarabia F, Ninkovic S, Finlay M, Boddy C. Variation der Ringgröße von Epothilonen – Totalsynthese von [14]-, [15]-, [17]- und [18]Epothilon A. Angew Chem Int Ed Engl 1998. [DOI: 10.1002/(sici)1521-3757(19980116)110:1/2<85::aid-ange85>3.0.co;2-g] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
22
|
Ring-Closing Metathesis in the Synthesis of Epothilones and Polyether Natural Products. TOP ORGANOMETAL CHEM 1998. [DOI: 10.1007/3-540-69708-x_3] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
23
|
Nicolaou KC, Sarabia F, Finlay MRV, Ninkovic S, King NP, Vourloumis D, He Y. Total Synthesis of Oxazole- and Cyclopropane-Containing Epothilone B Analogues by the Macrolactonization Approach. Chemistry 1997. [DOI: 10.1002/chem.19970031212] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|